| Metric | Details |
|---|---|
| Entity / Legal Name | BioLife Plasma Services LP (Takeda Form 20-F subsidiary list) |
| Parent Company | Takeda Pharmaceutical Company Limited |
| Issuer Credit Ratings (Takeda) | S&P: BBB+ (Stable) / Moody’s: Baa1 (Stable) |
| Investment Grade Status | Parent Rated Investment Grade (Takeda Pharmaceutical Company Limited); confirm the lease guarantor |
| Sector | Plasma Collection / Biopharmaceuticals |
| US Center Count | 238 (company website, October 2026) |
| Median asking cap rate | Too few current listings to report; see comparable tenants in the live table below |
| Typical Lease Term | Varies; confirm in the lease |
| Guarantee Type | Varies; confirm the tenant entity and any Takeda guaranty in the lease |
| Parent Stock Ticker | TAK (NYSE, ADS); 4502 (Tokyo Stock Exchange) |
| Parent Annual Revenue | JPY 4,505.7 billion (fiscal year ended March 31, 2026, Form 20-F) |
| Typical Building Size | Varies; confirm for each property |
BioLife Plasma Services Business Overview & NNN Investment Profile
BioLife Plasma Services says it operates 238 plasma donation centers across the U.S. (company website, October 2026). BioLife is a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, a Japan-based global biopharmaceutical company with revenue of JPY 4,505.7 billion in the fiscal year ended March 31, 2026 (Form 20-F), whose plasma-derived therapies unit, which includes its immunoglobulin and albumin products, manages that business from plasma donation through manufacturing. Takeda’s ownership does not by itself guarantee every BioLife lease; confirm the tenant entity and any Takeda guaranty on each property before relying on Takeda’s investment grade credit.
Plasma Centers as NNN Properties
BioLife centers separate plasma from donors’ blood through plasmapheresis, and the plasma is used to produce treatments and therapies (company website). Takeda’s immunoglobulin products, used mainly to treat primary immunodeficiency, chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy, had sales of JPY 790.6 billion in the fiscal year ended March 31, 2026 (Form 20-F).
We have no data on how often plasma centers relocate; confirm the remaining term and any early termination rights in each lease.
BioLife NNN Lease Structure
Initial terms, rent escalations and building sizes vary by property, so confirm the term, escalations and size in each lease.
BioLife NNN Cap Rate & Pricing
Live asking cap rates for BioLife Plasma Services and comparable tenants:
| Tenant | S&P / Moody’s | Median asking cap rate | Middle half of listings | Listings | Median vs. 10-year Treasury |
|---|---|---|---|---|---|
| Fresenius Medical Care | BBB- / Baa3 | 6.75% | 6.25% to 7.25% | 9 | +151 bps |
| DaVita | BB / n/a | 6.75% | 6.15% to 7.30% | 37 | +151 bps |
Active listings InvestmentGrade.com tracks with an asking cap rate (stated in the listing, or computed from its stated income and price when no rate is stated), listings last observed October 16, 2026. Asking cap rates are not closed-sale cap rates. The middle half is the range from the 25th to the 75th percentile of listings. The 10-year Treasury yield is 5.24% as of October 1, 2026 (FRED series DGS10). Ratings are the agency ratings in our ratings database for the entity shown, which may be a parent company; the rating type (for example issuer, senior unsecured debt, long-term debt or revenue bond ratings) varies by company and is shown on each tenant page. A rating applies to a lease only if the rated entity signs or guarantees it, so confirm the tenant and any guarantor in the lease. n/a means no verified rating is on file. Not shown because fewer than 3 active listings with a published cap rate were observed: BioLife Plasma Services, CSL Plasma.
Takeda’s BBB+/Baa1 parent credit applies where Takeda is the tenant or guarantor. Octapharma Plasma has no verified credit rating in our database, and CSL Plasma’s parent CSL Limited is rated A-/A3. The live table leaves out tenants with fewer than three active listings that show a cap rate, so BioLife may not appear in it; in that case compare a BioLife property on its lease terms and with the comparable tenants shown.
Comparable NNN Tenants
| Comparable Tenant | Rating |
|---|---|
| CSL Plasma (CSL Behring) | A-/A3 |
| Fresenius | BBB-/Baa3 |
| DaVita Dialysis | BB |
Is BioLife Plasma investment grade?
Its parent is. BioLife Plasma Services is a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, which carries issuer ratings of BBB+ from S&P and Baa1 from Moody’s (Form 20-F), both investment grade. Whether that credit backs a specific BioLife lease depends on whether Takeda signed or guaranteed it.
What are the asking cap rates for BioLife Plasma NNN properties?
The live table on this page shows current median asking cap rates for comparable tenants, and for BioLife Plasma Services once we track at least three active BioLife listings with a published cap rate. Pricing for a specific property depends on the remaining lease term, rent level, location and lease guarantor, and asking cap rates are not closed-sale cap rates.
BioLife Plasma Net Lease Property: Buying, Selling and Financing
Buying: We find on-market and off-market BioLife Plasma properties, review the lease and the tenant’s credit, and compare pricing with current listings. On the majority of transactions, there is no separate fee to you as the buyer; the listing broker pays a cooperating commission.
Selling: We can prepare an opinion of value from current listings and recent sales and, when it fits your goals, run a confidential sale to private investors, family offices and institutional buyers. See our guide to off-market sales.
Financing: Investment Grade Capital, a service of Investment Grade LLC, matches buyers and owners with lenders for acquisitions and refinancing.
1031 exchanges: Tell us your identification and closing deadlines so we can plan the search around them.
Request an NNN investment consultation or email team@investmentgrade.com.
Related NNN Tenants
- Ascension
- Aspen Dental
- Athletico
- Concentra
- Corewell Health
- CSL Plasma
- DaVita Dialysis
- EyeCare Partners
- Fresenius
- Grifols
- Henry Ford Health
- HCA Healthcare
- Heartland Dental
- Mary Washington Healthcare
- McLaren Health Care
- Oak Street Health
- Piedmont Healthcare
- Sparrow Health
- Trinity Health
- U of M Health
- University of Pittsburgh Medical Center (UPMC)
- Acadia Healthcare
- AFC Urgent Care
- ATI Physical Therapy
- CityMD / Summit Health
- Encompass Health
- Fast Pace Urgent Care
- MedExpress Urgent Care
- MyEyeDr
- NextCare Urgent Care
- Octapharma Plasma
- Pacific Dental Services
- Select Physical Therapy
- Smile Brands
- VCA Animal Hospitals
- WellNow Urgent Care
- Banfield Pet Hospital
- Labcorp
- National Vision
- Quest Diagnostics
BioLife Plasma Services NNN Properties Observed For Sale
1 active BioLife Plasma Services net lease listing observed across public listing sources, most recently Oct 16, 2026. Asking figures as published by the listing party.
| Location | Asking Price | Cap Rate | Building SF | Term Left | |
|---|---|---|---|---|---|
| LONGMONT, CO | $8,563,000 | 7.15% | 16,694 | 4.3 yrs | View listing |
Search all 1 observed BioLife Plasma Services listings and the full NNN inventory
Market observations aggregated from listing broker materials; not offerings by Investment Grade Income Property, LP. Buyer representation available on a cooperating commission basis. Information deemed reliable but not guaranteed.
